Duplicate Document
This document appears to be a copy. The original version is:
EFTA Document EFTA01493716Case File
efta-efta01493716DOJ Data Set 10CorrespondenceEFTA Document EFTA01493716
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01493716
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Summary
Ask AI About This Document
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
FINANCIAL TRUST COMPANY INC ACCT.
For the Period 12/1/12 to 12/31/12
Note:
** Unrealized Gainloss is shown as "N/A" in cases where we do not have appropriate cost information for all tax lots comprising the posdion Please contact your J.P. Morgan team for additional
information.
Equity Detail
Price
Quantity
Value
Adjusted Tax Cost
Unrealized
Gain/Loss
Est. Annual Inc.
Yield
Original Cost
Accrued Div.
US Large Cap Equity
ARIAD PHARMACEUTICALS INC
19.18
16,535.000
317,141.30
251,475.52
65,665.78
04033A-10-0 ARIA
BIOGEN IDEC INC
148.37
2,095.000
306,645.15
250,454.95
56,190.20
09082X-10-31311B
DEAN FOODS CO
16.51
25,000.000
412,750.00
470,439.75
(57,689.75)
242370-10-4 DF
FACEBOOK INC-A
26.62
465,850.00
665,000.00
(199,150.00)
17,500.000
30303M-10-2 FB
Total US Lary Cap Equity
01,602,380.45
51.637 370 22
($134,083.77)
*0.00
0.00%
US Small/Mid Cap Equity
DEUTSCHE BK AG LDN BRH
11.79
50,000.000
589,500.00
352,529.00
236,971.00
DBL LONG ETN38
25154H55.8 DAG
JP Morgan
Account
Page 5 of 32
Consolidated Statement Page 8
Confidential Treatment Requested by JPMorgan
Chase
CONFIDENTIAL
JPM-SDNY-00016614
SDNY_GM_00285812
EFTA01493716
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.